Tasuku KitadaPresident and Head of R&D at Strand TherapeuticsSpeaker
Agenda Sessions
Intratumoral (STX-001) and Intravenous (STX-003) Delivery of LNP repRNA IL-12 for Immunotherapy of Solid Tumors
, 2:15pmView Session